
Kevin Lilly has served as senior vice-president at Mimedx and as senior vice president of marketing and product management at Standard Register Healthcare. With over 30 years of sales experience in the medical technology sector, Kevin Lilly specializes in selling regenerative medical treatment options to hospitals and outpatient clinics, among other products.
Regenerative medicine focuses on human cells. It seeks to replace organs and tissues that have been damaged by trauma, diseases, or congenital issues and aims primarily to treat symptoms.
An injured body has the innate capacity to defend and heal itself, but regenerative medicine has the power to accelerate the healing process.
The main areas of focus for regenerative medicine are cellular therapies, which involve the use of harvested cells that are injected into a disease-affected area of the body to aid recovery. These cells may come from various parts of the body, including the muscles, bone marrow, blood, or fat.
Another area of focus for regenerative medicine is biomaterials and tissue engineering. This approach is used to implant tissue into the body and to facilitate its regrowth. Emerging areas of regenerative medicine include the transplant of artificial organs and the use of medical devices that focus on the replacement and transplant of failing organs.


